Pharma is approaching continuous manufacturing with caution. However, equipped with fresh technical experience, plus decades of process design and control science across chemical synthesis and manufacture, pharma’s confidence is growing in continuous manufacturing’s cost, quality and risk-controlling benefits and its potential application to a broader range of oral solid dose processing environments.
ADVANCING SOLID DOSE PROCESSING EFFICIENCY AND EFFECTIVENESS
PHARMA’S ALMANAC GLOBAL PHARMACEUTICAL SUPPLY CHAIN TRENDS Q1 2017
BY ED GODEK AND STEPHEN SIRABIAN, GLATT AIR TECHNIQUES, INC.
BY ED GODEK AND STEPHEN SIRABIAN, GLATT AIR TECHNIQUES, INC.